Insulin resistance: causes, mechanisms, and clinical importance

Physiology and pathophysiology

Insulin acts through specific receptors on target tissues, notably skeletal muscle, adipose tissue and the liver. In muscle and fat, insulin promotes glucose transport into cells; in the liver it suppresses glucose production. Insulin resistance reflects defects at several points in this signaling network, including receptor function, intracellular signaling pathways and glucose transporter activity. The net result is impaired suppression of hepatic glucose output and reduced peripheral glucose uptake.

Causes and risk factors

Multiple factors contribute to insulin resistance. Common and well-established risks include excess body fat—particularly abdominal adiposity—physical inactivity, older age and a family history of metabolic disease. Certain medications and medical conditions can worsen sensitivity. Insulin resistance is strongly associated with the cluster of abnormalities known as metabolic syndrome and is a central feature in many cases of diabetes mellitus, especially type 2 diabetes. It may also be present in people with latent autoimmune diabetes of adulthood and can be relevant in reproductive conditions such as polycystic ovary syndrome.

Clinical presentation and complications

Insulin resistance itself often causes no obvious symptoms early on. As glucose regulation deteriorates, individuals may notice increased thirst, more frequent urination, tiredness and blurred vision. Chronic elevations of blood glucose increase the risk of cardiovascular disease, kidney disease, nerve damage, eye disease and poor wound healing. Because insulin resistance commonly precedes type 2 disease, early identification is important for prevention and risk reduction.

Diagnosis and assessment

There is no single diagnostic test for insulin resistance widely used in routine practice. Clinicians rely on clinical risk assessment and blood tests that reflect glucose control such as fasting plasma glucose, oral glucose tolerance tests and glycated hemoglobin. Measurement of fasting insulin, and calculated indices (for example HOMA‑IR) or dynamic tests used in research, can estimate insulin sensitivity. Evaluating related features such as blood pressure, lipid abnormalities and waist circumference helps identify metabolic risk.

Management

First-line management emphasizes lifestyle interventions: achieving and maintaining a healthy weight, regular aerobic and resistance exercise, and dietary changes that reduce excess calorie intake and improve nutrient quality. These measures improve insulin sensitivity and reduce the chance of progression to overt diabetes. When lifestyle changes alone are insufficient, medications may be used. Some agents, notably metformin and thiazolidinediones, improve insulin sensitivity; other glucose-lowering drugs reduce hyperglycemia by different mechanisms and may be chosen based on individual needs. In selected individuals with severe obesity, bariatric surgery can produce substantial and sustained improvements in insulin resistance and glucose control.

Prevention and public health

Population strategies that promote physical activity, healthy diets and environments that support weight management are central to preventing insulin resistance at scale. Early identification of at-risk individuals, together with counselling and structured programs, can delay or prevent progression to type 2 diabetes and reduce long-term complications.

Research directions and notable points

Active research areas include the molecular mechanisms of insulin signaling, the role of chronic low‑grade inflammation, adipose tissue biology, and interactions with the gut microbiome. There is interest in personalized prevention strategies and in identifying which interventions most effectively restore sensitivity in different populations. Clinicians emphasize that early lifestyle action remains the most evidence-based approach to limit harm from insulin resistance.

• Key links: hormone insulin, blood glucose, metabolic syndrome
• Associated disorders: diabetes mellitus, especially type 2 diabetes, and some cases of latent autoimmune diabetes
• Important concept: elevated hyperglycemia results from reduced cellular uptake and increased hepatic glucose output
• Patient advice: focus on weight control, physical activity and regular medical follow-up